info@sanjarpharma.com Himatnagar, Gujarat, India
Sanjar logo

Dry Powder Injections

Scroll Down To Discover

The Strategic Choice for High-Stability Injectables

Delivering pharmaceutical excellence through sterile dry powder formulations that provide superior product stability, extended shelf life, and reliable therapeutic efficacy.

At Sanjar Pharma LLP, we specialize in the manufacturing of sterile dry powder injections designed for medications that remain unstable in liquid form. Our advanced pharmaceutical manufacturing facility in Himatnagar, Gujarat, is engineered to meet international standards for Small Volume Parenteral (SVP) production, ensuring exceptional quality, safety, and potency in every vial.

Why Choose Dry Powder Injections?

Dry powder injectable formulations are widely preferred in modern healthcare due to their superior chemical stability and storage advantages. These products are commonly manufactured using advanced lyophilization (freeze-drying) or precision sterile powder filling technologies.

Compared to conventional liquid injections, dry powder formulations offer several important pharmaceutical and clinical benefits:

  • Enhanced Product Stability: Many Active Pharmaceutical Ingredients (APIs) rapidly degrade in the presence of moisture. Dry powder technology significantly improves chemical stability by eliminating water exposure.
  • Extended Shelf Life: Moisture-free formulations reduce the risk of microbial contamination and chemical degradation, resulting in longer shelf stability and dependable product performance.
  • Preservative-Free Formulation: Dry injections often eliminate the need for preservatives, minimizing the possibility of adverse reactions in sensitive patients.
  • Ease of Transportation: Their improved room-temperature stability makes dry powder injections ideal for global distribution, emergency healthcare systems, and remote medical environments without refrigeration infrastructure.

Advanced Dry Powder Injection Manufacturing Process

Sanjar Pharma LLP operates highly automated and carefully controlled manufacturing lines for the production of sterile dry powder injections. Every stage is executed under strict GMP-compliant procedures to ensure sterility, dosage precision, and pharmaceutical consistency.

1. Formulation & API Selection

We utilize only high-quality injectable-grade Active Pharmaceutical Ingredients (APIs) sourced from trusted suppliers. Every batch undergoes detailed inspection and analytical verification before entering the production cycle to ensure compliance with stringent pharmaceutical quality standards.

2. Aseptic Filling & Sealing Process

Our sterile manufacturing environment is designed to prevent contamination during every stage of production. Operations are conducted within advanced clean room facilities operating under Grades A and B environments.

  • Precision Dosing: Advanced filling machines accurately dispense the exact quantity of sterile powder or lyophilized material into each vial.
  • Immediate Stoppering: Sterile rubber stoppers are applied immediately after filling to protect the formulation from moisture and airborne contaminants.
  • Final Sealing: Each vial is secured using aluminum crimping or heat-sealing systems to ensure tamper-proof packaging and long-term sterility.

3. Sterility Assurance & Utility Infrastructure

Our facility is supported by advanced pharmaceutical utilities and environmental control systems that maintain the highest standards of GMP compliance and sterile manufacturing integrity.

  • Nitrogen Generation Systems: We utilize 99.95% pure nitrogen for filtration and inerting applications to protect sensitive pharmaceutical formulations.
  • Advanced HVAC Systems: 24 dedicated Air Handling Units (AHUs) equipped with HEPA filtration precisely control humidity, pressure, airflow, and temperature within production areas.

Specialized Therapeutic Applications

Sanjar Pharma LLP manufactures dry powder injections across multiple therapeutic categories to support critical healthcare treatments in India and more than 30 countries worldwide.

Our Dry Powder Injection Portfolio Includes:

  • Antibiotics & Antibacterials: Including Ceftriaxone, Cefuroxime, and Colistimethane Sodium injections for the treatment of severe bacterial infections.
  • Antimalarial Injections: Artesunate for Injection available in 30mg, 60mg, and 120mg strengths for the treatment of severe malaria.
  • Critical Care & Proton Pump Inhibitors (PPIs): Including Pantoprazole and Esomeprazole injections for acute gastrointestinal care.
  • Anti-Inflammatory & Steroid Injections: Including Methylprednisolone and Hydrocortisone Sodium Succinate formulations.

Uncompromising Quality Standards

As a WHO-GMP, GLP, and ISO-certified pharmaceutical company, Sanjar Pharma LLP is committed to maintaining the highest levels of product quality, patient safety, and manufacturing excellence.

Guided by our philosophy, "CARE IS GROWTH", every batch of dry powder injection undergoes extensive analytical and microbiological testing in our advanced Quality Control laboratories.

Our quality testing infrastructure includes:

  • HPLC analysis for potency and assay testing
  • FTIR testing for identity verification
  • Microbial and sterility testing
  • Comprehensive quality validation procedures

No pharmaceutical product is released into the market without final approval from our dedicated Quality Assurance (QA) department.

Partner with Sanjar Pharma LLP

Partner with Sanjar Pharma LLP for reliable, globally compliant, high-stability dry powder injectable solutions developed to meet the growing international demand for advanced healthcare products.

FILTER PRODUCTS
Search